Telegram Group & Telegram Channel
🔔 India’s HealthKart valued at $500M in new investment

HealthKart, India’s largest consumer nutrition platform, raised $153 million in a secondary investment, boosting its valuation to $500 million. Co-led by ChrysCapital and Motilal Oswal, this round saw exits from previous investors, including Peak XV. The startup, which reported $118.5 million in revenue for FY 2024, plans to expand as India’s sports nutrition market grows.

đź”— Source

🛡 Powered by V3V Ventures
Please open Telegram to view this post
VIEW IN TELEGRAM



group-telegram.com/venture_tg/4928
Create:
Last Update:

🔔 India’s HealthKart valued at $500M in new investment

HealthKart, India’s largest consumer nutrition platform, raised $153 million in a secondary investment, boosting its valuation to $500 million. Co-led by ChrysCapital and Motilal Oswal, this round saw exits from previous investors, including Peak XV. The startup, which reported $118.5 million in revenue for FY 2024, plans to expand as India’s sports nutrition market grows.

đź”— Source

🛡 Powered by V3V Ventures

BY Venture Capital


Warning: Undefined variable $i in /var/www/group-telegram/post.php on line 260

Share with your friend now:
group-telegram.com/venture_tg/4928

View MORE
Open in Telegram


Telegram | DID YOU KNOW?

Date: |

And while money initially moved into stocks in the morning, capital moved out of safe-haven assets. The price of the 10-year Treasury note fell Friday, sending its yield up to 2% from a March closing low of 1.73%. "Markets were cheering this economic recovery and return to strong economic growth, but the cheers will turn to tears if the inflation outbreak pushes businesses and consumers to the brink of recession," he added. The regulator said it has been undertaking several campaigns to educate the investors to be vigilant while taking investment decisions based on stock tips. As a result, the pandemic saw many newcomers to Telegram, including prominent anti-vaccine activists who used the app's hands-off approach to share false information on shots, a study from the Institute for Strategic Dialogue shows. "The argument from Telegram is, 'You should trust us because we tell you that we're trustworthy,'" Maréchal said. "It's really in the eye of the beholder whether that's something you want to buy into."
from cn


Telegram Venture Capital
FROM American